KRAS Status Doesn’t Impact Treatment with 5-FU Alone

Posted by Kate Murphy on August 2nd, 2008

While researchers have found that colorectal cancer tumors that have mutated KRAS genes don’t respond to treatment with EFGR inhibitors Erbitux®(cetuximab) and Vectibix™(panitumumab), is the same thing true for other drugs?

5-FU (fluorouracil) is the backbone of most colorectal cancer treatment, given alone or in combination with other drugs.  What does KRAS status mean when 5-FU is the only treatment? Read the rest of this entry »

Tags: , , Comments (0): Add a comment

C3 Advocates LIVESTRONG in Columbus

Posted by Suzanne Lindley on August 1st, 2008

The Lance Armstrong Foundation inspired and empowered 1,000 delegates to travel to Columbus, OH and support the Foundation’s efforts to make cancer a national priority…I was one of them.

The Summit took place July 24-27 at THE Ohio State University campus. Registration was the first step to the Summit. There we learned of our breakout sessions and were given LIVESTRONG yellow shirts to wear. They were catchy with “Vote Yellow” on the front and a definition on the back which read:

“Vote Yellow” ”(vot • yel-o)

(1. n. An expression of choice made by 12 million cancer survivors and their loved ones. 2. v. To declare one’s opinion that our leaders should make cancer a national priority. 3. n. A philosophy believing it unacceptable to lose 560,000 Americans to cancer each year. 4. n. LIVESTRONG!™

Read the rest of this entry »

Comments (1): Add a comment
Page 5 of 512345